SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
-12.6%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$323M
AUM Growth
+$323M
(+14%)
Cap. Flow
+$76.9M
Cap. Flow
% of AUM
23.79%
Top 10 Holdings %
Top 10 Hldgs %
57.75%
Holding
63
New
17
Increased
10
Reduced
12
Closed
6
Top Buys
| 1 |
Globus Medical
GMED
|
$15.1M |
| 2 |
Pfizer
PFE
|
$14.9M |
| 3 |
Teleflex
TFX
|
$12.7M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$12.6M |
| 5 |
Medtronic
MDT
|
$8.68M |
Top Sells
| 1 |
GE HealthCare
GEHC
|
$24.3M |
| 2 |
Cigna
CI
|
$15.6M |
| 3 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$8.28M |
| 4 |
PDCO
Patterson Companies, Inc.
PDCO
|
$8.15M |
| 5 |
Humana
HUM
|
$5.81M |
Sector Composition
| 1 | Healthcare | 99.97% |
| 2 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Labcorp
LH
$23.1B
| $33.9M | 10.5% | 168,809 +26,903 | +19% | +$5.41M |
|
|
2
Globus Medical
GMED
$8.27B
| $25.7M | 7.94% | 516,981 +304,388 | +143% | +$15.1M |
|
3
GSK
GSK
$79.9B
| $18.5M | 5.71% | 509,000 +29,468 | +6% | +$1.07M |
|
4
United Therapeutics
UTHR
$13.8B
| $18.4M | 5.71% | 81,606 +1,680 | +2% | +$379K |
|
|
5
Cigna
CI
$80.3B
| $16.7M | 5.16% | 58,226 -54,448 | -48% | -$15.6M |
|
|
6
GE HealthCare
GEHC
$33.7B
| $16.5M | 5.1% | 242,308 -357,500 | -60% | -$24.3M |
|
|
BCYC
7
Bicycle Therapeutics
BCYC
$511M
| $16M | 4.96% | 796,933 -171,738 | -18% | -$3.45M |
|
|
8
Pfizer
PFE
$141B
| $14.9M | 4.63% | +450,700 | New | +$14.9M |
|
9
Organon & Co
OGN
$2.45B
| $13.3M | 4.12% | 767,000 +362,062 | +89% | +$6.29M |
|
|
10
Teleflex
TFX
$5.59B
| $12.7M | 3.92% | +64,491 | New | +$12.7M |
|
|
11
Regeneron Pharmaceuticals
REGN
$61.5B
| $12.6M | 3.88% | +15,250 | New | +$12.6M |
|
|
12
Medtronic
MDT
$119B
| $8.68M | 2.69% | +110,780 | New | +$8.68M |
|
13
Embecta
EMBC
$847M
| $8.55M | 2.65% | +568,294 | New | +$8.55M |
|
14
Healthcare Services Group
HCSG
$1.13B
| $8.45M | 2.62% | +810,307 | New | +$8.45M |
|
15
Orthofix Medical
OFIX
$592M
| $8.36M | 2.59% | +650,000 | New | +$8.36M |
|
16
Zimmer Biomet
ZBH
$21B
| $8.24M | 2.55% | +73,400 | New | +$8.24M |
|
17
Travere Therapeutics
TVTX
$1.56B
| $7.91M | 2.45% | +884,770 | New | +$7.91M |
|
18
Viking Therapeutics
VKTX
$3.04B
| $6.59M | 2.04% | 595,002 +67,345 | +13% | +$746K |
|
|
GRCL
19
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $5.99M | 1.86% | +2,081,216 | New | +$5.99M |
|
20
BridgeBio Pharma
BBIO
$9.89B
| $5.88M | 1.82% | +222,947 | New | +$5.88M |
|
|
CNTA
21
Centessa Pharmaceuticals
CNTA
$2.25B
| $4.9M | 1.52% | 756,891 -120,302 | -14% | -$778K |
|
22
ARS Pharmaceuticals
SPRY
$1.15B
| $4.18M | 1.29% | 1,105,911 +563,335 | +104% | +$2.13M |
|
23
Protagonist Therapeutics
PTGX
$3.67B
| $4.14M | 1.28% | +248,127 | New | +$4.14M |
|
|
KRTX
24
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $4.08M | 1.26% | +24,129 | New | +$4.08M |
|
|
RVNC
25
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.93M | 1.22% | 342,477 +200,977 | +142% | +$2.31M |
|